Joining us on this episode is Tom Neyarapally, co-founder and CEO of Archetype Therapeutics, an exciting new AI-driven company in the drug discovery space. Archetype is an AI-native biotech pioneering the use of generative chemogenomics and patient clinicogenomic data to virtually screen billions of potential drug candidates each day.

⁠⁠TPM E47 highlights >⁠⁠⁠⁠⁠⁠⁠⁠

Episode 47 links:

• Archetype Therapeutics
• Tom Neyarapally on LinkedIn 
• “Exploring a “Patient-First” Path in Drug Discovery”, a LinkedIn article by Tom Neyarapally, Paul McDonagh, and Rafael Rosengarten